MED SURG TEST 2 Flashcards

1
Q

BP

A

the force exerted by the blood against the walls of the blood vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CO

A

the total blood flow through the systemic or pulmonary circulation per minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stroke Volume

A

the amount of blood pumped out of the left ventricle (70ml) multiplied by the HR for 1 minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypertension

A
Persistent elevation of :
Systolic blood pressure ≥140 mm Hg
»OR
Diastolic blood pressure ≥90 mm Hg 
»OR
Current use of antihypertensive medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prehypertension

A

Systolic BP: 120 to 139 mm Hg
»OR
Diastolic BP: 80 to 89 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Isolated Systolic Hypertension (ISH)

A

oAverage SBP > 140 mm Hg & DBP < 90 mm Hg
or loss of elasticity from atherosclerosis
ISH is more common in older adults because of changes in BP patterns. SBP rises with aging, and DBP rises until approximately age 55 and then declines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pseudo Hypertension

A

Advanced atherosclerosis –don’t collapse
Sclerotic arteries do not collapse when the cuff is fully inflated. This results in much higher cuff pressures than are actually present within the vessels. Suspect pseudohypertension if arteries feel rigid, or when few retinal or cardiac signs are found relative to the pressures obtained by cuff.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary (essential or idiopathic) hypertension

A

Elevated BP without an identified cause

- 90% to 95% of all cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Secondary Hypertension

A

Elevated BP with a specific cause
Contributing Factors
Coarctation of aorta (narrowing)
Renal disease (artery stenosis)
Endocrine disorders (Cushing syndrome, thyroid disease)
Neurologic disorders (brain tumors)
Cirrhosis
Sleep apnea
Cocaine
•Treatment of is aimed at eliminating the underlying cause
•Secondary hypertension is a contributing factor to hypertensive crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk Factors for Primary Hypertension

A
•Age
•Alcohol
•Cigarette smoking
•Diabetes mellitus
•Elevated serum lipids
•Excess dietary sodium
•Gender
•Family history
•Obesity
•Ethnicity
•Sedentary lifestyle
•Socioeconomic status
Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contributing Factors for Primary Hypertension

A

•Heredity
•Water and Na retention
oHigh sodium intake may activate a number of pressor mechanisms, resulting in water retention.
•Altered renin-angiotensin aldosterone mechanism
oContributes to the development of HTN
•Stress and increased SNS
oIncrease vasoconstriction, increased HR, renin release
•Insulin resistance
oHigh insulin concentration stimulates SNS activity, impairs nitric oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypertension Symptoms

A
•Symptoms are often secondary to organ damage and can include 
oFatigue, reduced activity tolerance
oDizziness
oPalpitations, angina
oDyspnea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostic Studies of Hypertension

A

•History and physical examination
•Bilateral BP measurement
oUse arm with higher reading for subsequent measurements.
oBP is highest in early morning, lowest at night.
•Use a properly calibrated instrument.
•Patient should be seated quietly for 5 minutes in a chair, with feet on the floor and arms supported at heart level.
•Use appropriately sized cuff to ensure accurate readings.
•Obtain at least two measurements on two visits.
•“White coat” phenomenon may precipitate the need for ambulatory blood pressure monitoring (ABPM).
oNoninvasive, fully automated system that measures BP at preset intervals over 24-hour period
•Urinalysis, creatinine clearance
•BMP-Serum electrolytes, glucose, BUN and serum creatinine
•CBC
•Serum lipid profile
•ECG
•Echocardiogram
**These test are usually performed to rule out secondary HTN, or to determine damage caused by uncontrolled HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Complications of Hypertension

A

Damage occurs most frequently in the
oHeart
oBrain
oPeripheral vasculature
oKidney
oEyes
•Hypertensive heart disease
oCoronary artery disease
oLeft ventricular hypertrophy
oHeart failure
•Cerebrovascular disease
oStroke (risk 4x higher)
•Peripheral vascular disease
oIncreased development of atherosclerosis, aortic aneurysm, aortic dissection
•Nephrosclerosis
oHTN leading cause of ESRD (especially among African Americans)
•Retinal damage
oBlurred vision, retinal hemorrhage, loss of vision
•Hypertension is a major risk factor for cerebral atherosclerosis and stroke. Even in mildly hypertensive people, the risk of stroke is 4 times higher than in normotensive people.
•Hypertension speeds up the process of atherosclerosis in the peripheral blood vessels, leading to the development of peripheral vascular disease, aortic aneurysm, and aortic dissection.
•Some degree of renal dysfunction is usually present in the hypertensive patient, even one with a minimally elevated BP. Renal dysfunction is the direct result of ischemia caused by the narrowed lumina of intrarenal blood vessels.
The appearance of the retina provides important information about the severity and duration of hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nursing Intervention for HTN

A

•Teach patients lifestyle modifications
oWeight reduction: Weight loss of 10 kg
(22 lb) may decrease SBP by approx. 5 to
20 mm Hg
oDASH eating plan
- Emphasizes vegetables, fruits, and fat-free or low-fat dairy products
- Includes whole grains, fish, poultry, beans, seeds, nuts, and vegetable oils
- Limits sodium, sweets, sugary beverages, and red meats
In terms of nutrition content, DASH is:
-Low in saturated and trans fats
- Rich in potassium, calcium, magnesium, fiber, and protein
- Dietary sodium reduction: <1500mg of sodium/day
oModeration of alcohol consumption:
§Men: No more than 2 drinks/day
§Women: No more than 1 drink/day
•When a person decreases caloric intake, sodium and fat intakes usually are also reduced. Although reducing the fat content of the diet has not been shown to produce sustained benefit for BP control, it may slow the progress of atherosclerosis and reduce overall CVD risk.

oPhysical activity: Regular physical (aerobic) activity, at least 30 minutes, most days of the week
oAvoidance of tobacco products
oPsychosocial risk factors
§Socioeconomic status, social isolation, lack of support, stress at work and family life, and depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Medication Interventions for HTN

A

•Drug therapy: Classifications of common drugs used to treat hypertension
oDiuretics-Furosemide
oB-Adrenergic inhibitors -Metoprolol
oDirect vasodilators-Clonidine
oAngiotensin-converting enzyme inhibitors
§Lisinopril
oAngiotensin II receptor blockers-Valsartan
oCalcium channel blockers-Amlodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Side Effects of Cardiac Medications

A
•Drug therapy and patient teaching
oIdentify, report, and minimize side effects.
§Orthostatic hypotension
§Sexual dysfunction
§Dry mouth
§Frequent urination
§Electrolyte imbalance (K, Mg)
§Some side effects may decrease over time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nursing Diagnoses for HTN

A
oIneffective health maintenance 
oAnxiety 
oSexual dysfunction 
oIneffective self-health management 
oDisturbed body image 
oIneffective tissue perfusion 
oRisk for falls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What Happens when HTN Occurs in Older Adults?

A
  • Isolated systolic hypertension (ISH): Most common form of hypertension in individuals age >50.
  • Older adults are more likely to have “white coat” hypertension.
  • Often a wide gap between the first Korotkoff sound and subsequent beats is called the ausculatory gap.
  • Failure to inflate the cuff high enough may result in serious underestimation of the SBP.
  • Older adults have varying degrees of impaired baroreceptor reflex mechanisms.
  • Consequently, orthostatic hypotension occurs often, especially in patients with ISH.
  • Altered metabolism of medications.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hypertensive Emergency

A
oSevere increase in BP (>220/140mm Hg)
oEvidence of acute organ damage, especially in the CNS
•Develops over hours to days
•Often occurs in patients with a history of HTN who have failed to comply with medications or who have been under medicated
•Secondary HTN is contributing cause
•Evidence of acute organ damage: 
oHypertensive encephalopathy, cerebral hemorrhage 
oAcute renal failure
oMyocardial infarction
oHeart failure with pulmonary edema
•Signs and symptoms of hypertensive encephalopathy: 
oSevere headache
oN/V
oSeizures, confusion 
oComa 
§Renal failure
§MI
§Pulmonary edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypertensive Urgency

A

develops over days to weeks. This is a situation in which a patient’s BP is severely elevated (180/110mmHg), but no clinical evidence of target-organ damage is found.
May or may not require hospitalization
•Managed with oral medications
•Requires frequent follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Nursing Interventions HTN Emergency

A

•Requires Hospitalization
oIV drug therapy: Titrated to decrease no more than MAP 25% in first hour (110-115mm Hg
oMonitor cardiac and renal function
oNeurologic checks
oDetermine cause
oEducation to avoid future crises
•When hypertensive emergencies are managed, mean arterial pressure (MAP) is often used instead of systolic and diastolic BP readings to guide and evaluate drug therapy.
•The initial treatment goal is to decrease MAP by no more than 25% within minutes to 1 hour. If the patient is stable, the goal for BP is 160/100 to 110 mm Hg over the next 2 to 6 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MAP

A

(SBP+2DBP)/3

§MAP at least 60, normally between 70-110

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

WBC

A

5,000 - 10,000/mm3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hbg

A

Male: 14-17.4 g/dL
Female: 12-16 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hct

A

Male: 42-52%
Female: 36-48%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Plt

A

140-400

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

BUN

A

6-20mg/dL

Elderly: 8-23mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Creatinine

A

Female: 0.4-1mg/dL
Male: 0.6 -1.2 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

BNP

A

<100pg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

PTT

A

60-70 sec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PT

A

11-13 sec (therapy > 1.5-2 times control)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

INR

A

0.8-1.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is the most common type of cardiovascular disease and accounts for the majority of these deaths?

A

Coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Patients with CAD can have two outcomes, what are they?

A

Asymptomatic or chronic stable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Atherosclerosis

A

Type of blood vessel disorder-major cause of CAD
oBegins as soft deposits of fat that harden with age
oReferred to as “hardening of arteries”
oCan occur in any artery in the body
oAtheromas (fatty deposits)
§Preference for the coronary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Nonmodifiable Risk Factors for CAD and ACS

A
•Age 
•Gender
•Ethnicity
•Family history
•Genetic predisposition
Vietnam Vets – Exposed to Agent Orange ext
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Modifiable Risk Factors for CAD and ACS

A
  • Elevated serum lipids (*LDL)
  • Hypertension
  • Tobacco use
  • Physical inactivity
  • Obesity
  • Diabetes
  • The incidence of CAD and MI is highest among white, middle-aged men.
  • After age 65, the incidence in men and women equalizes, although cardiovascular disease causes more deaths in women than in men.
  • Additionally, CAD is present in African American women at rates higher than in their white counterparts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Diagnostics Tests for CAD and ACS

A
•H&P
•Chest Xray
•ECG
•Lipid Profile 
•Cardiac catheterization
•Percutaneous Cardiac Intervention
oAngioplasty
oStenting-must be on 
o   antiplatelet therapy 
•CT (Electronic Beam)
oCalcium and plaque deposits
•Stress Test
oImpact of blood flow 
•ECG
•Echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Nursing Interventions for CAD

A

•Teach patients health-promoting behaviors
oLow fat, low cholesterol, low sodium diet
o30 minutes of physical on most days/week
oRegular physical activity contributes to
§Weight reduction
§Reduction of >10% in systolic BP
§Increase in HDL cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Medications for CAD

A
•β-Adrenergic Blockers-Preferred drug
oDecrease myocardial contractility, HR, SVR, BP 
•Calcium Channel Blockers
oVasodilation, decreased SVR, myocardial contractility
•Ace Inhibitors 
oDecrease risk for cardiac events (MI)
•Antiplatelet therapy
oASA-recommended for most people at risk
oClopidogrel (Plavix)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Gerontologic Considerations for CAD

A

•Strategies to reduce risk factors are effective but often under prescribed and under utilized
•Necessary to modify guidelines for physical activity (walking)-start slowly
oTwo points when elderly may consider lifestyle change(s):
§When hospitalized
§When symptoms result from CAD and not from normal aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Chronic Stable Angina

A

•Myocardial Ischemia
oDemand for myocardial O2 exceeds the ability of the coronary arteries to supply
•Angina
oChest pain caused by reversible myocardial ischemia
•Chronic Stable Angina
oCP that occurs intermittently over a long period of time with the same pattern of onset, duration, and intensity of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Diagnostic Tests for Chronic Stable Angina

A
  • H&P
  • CXR
  • ECG
  • Cardiac markers
  • Lipid Panel
  • Cardiac catheterization-Most Specific
  • Stress Test
  • Echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Chronic Angina Drug Therapy

A

•Drug therapy: Nitrates (short and long acting)
§preload and afterload
§myocardial O2 demand

•Administration:
oSublingual or spray: Quick, short acting
oNitroglycerin ointment
oTransdermal controlled-release nitroglycerin

•Side effects
oOrthostatic hypotension, dizziness, HA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Teaching for Chronic Stable Angina

A
•Medications
•Identify factors the precipitate angina
oWeather, large meals
•Low NA, low fat, low cholesterol diet
•Ideal body weight
•Physical activity
o30 min a day (most days)
•NTG use
•Smoking cessation

•A Antiplatelet/anticoagulant/antianginal
•B B blocker/blood pressure control
•C Cigarette smoking cessation, cholesterol
management, calcium channel blockers,
cardiac rehab
•D Diet, diabetes management, depression
•E Education, exercise
F Flu vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is PQRST used for and what does it stand for?

A
It is used to asses chest pain
P - Precipitating Events
Q - Quality of the pain
R - Radiation of pain 
S - Severity of Pain
T - Timing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What do ABCDEF stand for in Chronic Stable Angina teaching?

A

A - Antiplatelet/anticoagulant/antianginal
B - B blocker/ blood pressure control
C - Cigarette smoking cessation, cholesterol management, calcium channel blockers, cardiac rehab
D - Diet, diabetes management, depression
E - Education, exercise
F- Flu vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What is Acoronary Syndrome (ACS)

A

Ischemic discomfort resulting from plaque accumulation and/or rupture leading to thrombus formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What kind of chest pain occurs in an unstable angina?

A

New, occurs at rest, or has worsening pattern. It’s unpredictable and emergent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What are early warning signs of a heart attack?

A

Pressure in center of chest
Pain in shoulders, neck or arms
Chest discomfort with fainting, sweating or nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What are clinical manifestations of a MI?

A

Left chest pain, pressure, burning with or without radiation to left arm or jaw ( NOT releived by positioning, rest, or nitrates)
Diaphoresis, ashen, clammy, cool to touch
BP and HR elevated initially
BP and HR drops as CO is decreased
N/V
Fever- may increase in 1t 24 hrs
Crackles, JVD, hepatic engorgement, edema-may occur hours to days later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What are some atypical signs and symptoms of an MI in Women, Elderly, diabetics?

A

Women - fatigue, SOB, weakness, sleep disturbances, nausea, anxiety, dizziness, cold sweats
Elderly - Fatigue, weakness, abdominal pain, diaphoresis, n/v, dizziness, AMS
Diabetics - SOB, fatigue, weakness, abdominal pain, n/v, diaphoresis

54
Q

Diagnostic tests for MI

A

•H&P
•Characteristics of CP
•Serum cardiac markers
oReleased into the blood from necrotic heart muscle
•ECG
•Stress test (ONLY if cardiac markers are negative)
•Cardiac Catheterization

55
Q

Initial Treatment for an MI includes

A
•Assess ABC’s
•Position upright, administer  O2
•Obtain vs and pox
•Listen to heart and lungs
•Obtain 12 lead ECG-continuous monitoring
•Establish IV (2)
•Assess pain
•Medicate for pain (nitro, morphine)
oSublingual NTG q 5min X 3 (hold SBP <90)
•Baseline blood work
•Chest Xray
•Assess for contraindications for antiplatelet, anticoagulation, or thrombolytic therapy-PCI
•Administer ASA
Administer antidysrhythmics
56
Q

Ongoing treatment for an MI includes:

A
Angina with 
– Cardiac Markers
•Antiplatelet/anticoag
oASA and/or Heparin
•Coronary angiography 
•PCI (percutaneous Intervention)-angioplasty/stenting
STEMI or NSTEMI with
\+ Cardiac Markers 
•Thrombolytic therapy
•PCI
•Surgical revascularization
oCABG
57
Q

When is a patient a candidate for Coronary Surgical Revascularization?

A

oFail medical management
oPresence of left main coronary artery or three-vessel disease
oNot a candidate for PCI (e.g., lesions are long or difficult to access)
oFailed PCI with ongoing chest pain
oDiabetes

58
Q

What are some surgical intervention complications for Coronary Revascularization?

A
oCardiac arrhythmias-atrial fibrillation
oStroke 
oBleeding and anemia (incision site/chest tube)
oHypothermia
oF/E imbalances 
oRespiratory changes
oIncision site infections
oConstipation
oCognitive dysfunction
oSelf-concept changes
59
Q

What are some ACS Medications?

A
oNitroglycerin
oMorphine Sulfate
oAspirin
oβ-Adrenergic Blockers
oAce Inhibitor
oAntidysrhythmic drugs
oCholesterol lowering drugs
oStool softeners
60
Q

ACs Teaching

A

•Same as chronic stable angina
•S/S of MI, when to call for help
•Resumption of work, physical activity, sexual activity
•Measures to promote health and recovery
oS/S of infection/complication of MI/surgery

61
Q

ACS complications

A

oDysrhythmias(80% of patients)
oHeart failure (HF)
oCardiogenic shock
§Occurs when there is decreased CO
§S/S similar to HF
»Tachycardic, hypotensive, tachypneic, crackles
§Signs and symptoms of hypo-perfusion
»Cyanosis, pallor, diaphoresis, weak peripheral pulses, cool, clammy skin, delayed CRT
»Decreased renal blood flow-decreased urine output

62
Q

What is Ineffective Endocarditis

A

Infection of the inner layer of the heart that usually affects the cardiac valves
•Was almost always a fatal condition until development of penicillin
•Occurs when blood turbulence within heart allows causative agent to infect previously damaged valves or other endothelial surfaces
•Most commonly
ostaphylococcus aureus and streptococcus viridans
•Vegetation’s cause embolizations
oFibrin, platelets adhere to valve surface
•Rheumatic Heart disease

63
Q

Principle Risk Factors For Ineffective Endocarditis

A
oCardiac conditions
Prior endocarditis
Prosthetic valves 
Valve disease
Cardiac lesions
Congenital heart disease
Pacemakers
Marfan’s syndrome
Cardiomyopathy 
•Noncardiac
-Hospital acquired bacteremia
-IV drug abuse
•Procedure-Associated risks
-Intravascular devices
-Dental procedures
-Respiratory procedures
-GI and GU procedures
64
Q

Clinical Manifestations of Ineffective Endocarditis

A
oLow grade fever (90%),  Chills
oWeakness, malaise, fatigue
oAnorexia, weight loss
oArthralgias, myalgias, back pain
oVascular Manifestations 
oembolism-organ infarction
65
Q

Vascular Manifestations of Ineffective Endocarditis

A

a) Splinter hemorrhages in nail beds
b) Petechiae
c) Osler’s nodes on fingers or toes
d) Janeway’s lesions on palms or soles
e) Roth’s spots

66
Q

Tests Performed to Diagnose Ineffective Endocarditis

A

•Definitive diagnosis if 2 major criteria:
oPositive blood cultures (2 drawn 30 min apart)
oNew or changed murmur
oEchocardiogram shows intracardiac mass or vegetation
•Chest X-ray and ECG can provide more information on extent of disease
•WBS
•ESR

67
Q

Medications for Ineffective Endocarditis

A
•IV Antibiotic administration (4-6 wks)
oMonitor antibiotic serum levels (e.g., peak and trough) 
oSubsequent blood cultures
oMonitor renal function 
•Fungal and prosthetic valve endocarditis
oRespond poorly to antibiotics 
oMay need valve replacement
•Acetaminophen or Ibuprofen 

•Teach Prophylactic Treatment
oAntibiotics before dental or invasive procedures

68
Q

Nursing Interventions for Ineffective Endocarditis

A
•Increase activity slowly
•TEDS
•C&DB
•Observe for complications or worsening disease
•Teach
oRisk reduction
§Avoid sick people
§Good nutrition
oGood oral hygiene
§Antibiotics
oNotify HCP prior to invasive procedures for antibiotics
69
Q

Complications of Ineffective Endocarditis

A

•Dysrhythmias
•Valve dysfunction
•Heart failure
Sepsis

70
Q

Manifestations of Stenosis in the Mitral Valve

A
oExertional Dyspnea-reduced lung compliance
oFatigue and palpations-A-fib
oMurmur
•Less common
oHoarseness-atrial enlargement on laryngeal nerve
oHemoptysis-Pulmonary HTN
oCP-decreased co
oSeizure-embolism
oStroke-embolism
71
Q

Causes of Regurgitation

A

MI, Rheumatic heart disease, Mitral valve prolapse

72
Q

Manifestations of Regurgitation

A
oAcute
§New systolic murmur
§Pulmonary edema 
oChronic
§Asymptomatic for years 
§Weak, fatigued
§Dyspnea
§palpitations
§Audible S3
§murmur
73
Q

Mitral Valve Prolapse complications

A

oMitral valve regurgitation
oInfective endocarditis
oSudden death
oCerebral ischemia

74
Q

Mitral Valve Prolapse Clinical Manifestations

A
oDyspnea
oFatigue
oPalpitations
oDizziness and syncope
oTachycardia 
oAtypical chest pain
oMurmur
§Systolic
§Clicks
75
Q

Manifestations of Aortic Valve Stenosis

A
oAngina
oSyncope, exertional dyspnea
oNormal to soft S1, Diminished or absent S2
oMurmur
oLoud S4
oPoor Prognosis
76
Q

Aortic Valve Regurgitation Manifestations

A
•Acute Manifestations
oCP, HF
•Chronic Manifestations
oRemains asymptomatic for years
oExertional dyspnea
oOrthopnea
oParoxysmal nocturnal dyspnea 
oMurmur-diastolic
77
Q

Diagnostic Tests to Determine Valvular Heart Disease

A
  • H&P
  • Echocardiogram-valve structure, function and chamber size
  • ECG-rhythm and ischemia
  • Chest Xray-size of heart
  • Cardiac Cath-measure the pressures in the valve and the size of the valve opening
  • CBC Labs (infection)
78
Q

Valvular Heart Disease Findings

A
•Cardiovascular
oAbnormal heart sounds
oTachycardia, Dysrhythmias
oHypotension
•Respiratory:
oCrackles, wheezes, hoarseness
•Gastrointestinal
oAscites
oHepatomegaly
•Integumentary:
oDiaphoresis
oPeripheral edema
oTemperature 
oClubbing
79
Q

Treatment of Valvular Heart Disease

A
•Focus on preventing 
oExacerbations of heart failure
oAcute pulmonary edema
oThromboembolism
oRecurrent endocarditis
•Drug therapy
oDigitalis
oDiuretics 
oAntiarrhythmics
oβ-Blockers 
oAnticoagulants 
oAntibiotics
80
Q

Patient Teaching for Valvular Heart Disease

A
  • Anticoagulant
  • Prophylactic antibiotic
  • Low-sodium diet
  • Activity modifications
  • Oxygen therapy
  • Avoid infectious people
  • Avoid stress and fatigue
  • Rest
  • Hygiene
  • Signs and symptoms of infection
  • Stress follow-up care
  • Same as previous cardiac teaching
81
Q

What is the mechanical valve goal for INR?

A

2.5- 3.5

82
Q

Nursing Diagnoses for Valve Disease

A

oExcess fluid volume
oDecreased cardiac output
oActivity intolerance
oKnowledge Deficit

83
Q

What happens in Dilated Cardiomyopathy? Who does it effect most often?

A

The heart enlarges and becomes weaker. It’s most common in middle-aged African American and men

84
Q

What is Hypertrophic Cardiomyopathy?

A

Massive ventricular hypertrophy, rapid, forceful contraction of the L ventricle, impaired relaxation, obstruction of aortic outflow

85
Q

Causes of Dilated Cardiomyopathy

A

Cardio-toxic agents (alcohol, cocaine), CAD, Genetic, HTN

86
Q

Causes of Hypertrophic Cardiomyopathy

A

Aortic Stenosis, Genetic, HTN

87
Q

What are the manifestations of Dilated and Hypertrophic CardMeg?

A

D - fatigue, weakness, palpitations, dyspnes, HF symptoms

H - Exertional dyspnea, fatigue, angina, syncope, palpitations

88
Q

What are the diagnostic test of Dilated and Hypertrophic CardMeg?

A

D - Echo, Chest XRay, ECG, BNP, Cardiac Cath

H - Echo, ECG, Cardiac Cath, Stress Test

89
Q

What medications do you give to treat Cardiomyopathy?

A
oNitrates (except in hypertrophic causes worsening chest pain)
oB-adrenergic blockers
oAntidysrhythmics
oACE inhibitors
oDiuretics
oDigoxin (except in hypertrophic)
oAnticoagulants (if indicated)
90
Q

What invasive treatments are possible with Cardiomyopathy? D and H

A
•Dilated
oVentricular Assist device
oCardiac Transplant
oCardiac resynchronization
oImplantable cardioverter-defibrillator
oTransplant
•Hypertrophic
oCardiac resynchronization
oImplantable cardioverter-defibrillator
oSurgical correction (removing a portion of the ventricular muscle)
91
Q

What is important patient teaching in Cardiomyopathy? D and H

A

•All previous cardiac education
•Medication teaching
•Low Fat, Chol, and Na diet
•6-8 glasses of H2O (unless contraindicated)
•Maintain reasonable weight, avoid large meals
•Avoid alcohol, caffeine, OTC meds
•Reduce stress
•S/S of HF
oMay focus on end of life care
oSuggest caregiver learn CPR
•Avoid strenuous activity
•Any activity that causes in increase in systemic vascular resistance is dangerous and should be avoided
•Rest and elevation of the feet to improve venous return

92
Q

What can cause sinus bradycardia? What is it? What are some sings and symptoms? How can you treat it?

A

slower than normal hr cauased by a disruption of the electrical impulses. This can occur during sleep, in athletes, with a carotid massage, a valsalva maneuver, administration of beta blockers or ace
S/S
pale, cool skin, hypotension, weakness, angina, dizziness, syncope, confusion, SOB
Treatment
Atropine, pacemaker, adjust or hold medications

93
Q

What is sinus tachycardia? When does it occur? What are some sings and symptoms? How can you treat it?

A

Faster than normal d/t abnormal electrical impulses. This can occur with exercise, fever, pain, anxiety, increased caffeine, hypovolemia, anemia, hypoxia, MI, HF, administration of meds (atropine, epinephrine, Sudafed, theophyline)
S/S
decreased cardiac output, dizziness, dyspnes, and hypotension
can present as CP or cause an MI
Treatment
-treat cause, vagal maneuvers, beta blockers

94
Q

What are the signs of an atrial flutter?

A

saw toothed flutter waves, atrial rate of 200-350 bpm, and ventricular rates that vary with conduction ratio, decreased cardiac output.

95
Q

When can an atrial flutter occur?

A

oCAD, HTN, mitral valve disorders, COPD

96
Q

What are complications of an atrial flutter?

A

oHF, Thrombi formation (CVA, PE)

97
Q

What kinds of treatment options are available for atrial flutters?

A

goal to decrease ventricular rate
oB Blockers, antidysrhythmics, CC Blockers
oCatheter ablation (treatment of choice), Cardioversion if hemodynamically unstable
oLong term use of coumadin if Aflutter continues

98
Q

What is an atrial fib? When can it occur?

A
•Atrial rate 350-600 bpm
•Controlled ventricular rate 60-100
•Uncontrolled ventricular rate > 100
•Most common dysrhythmia
•Prevalence increases with age
•Can occur with:
oCAD, HTN, HF, valvular heart disease, alcohol intoxication, electrolyte disturbances, pericarditis
99
Q

What are s/s of atrial fib? What are complications?

A

•S/S
oDecreased cardiac output
•Complications:
oThrombi formation (CVA, PE)

100
Q

What are treatment options for Atrial fibrillation?

A

oCC blockers, B-Blockers, Cardioversion (1st choice) Catheter ablation or Maze procedure(2nd choice)
§Long term use of coumadin if Afib continues

101
Q

What are premature Ventricular Contractions?

A
  • Wide distorted QRS – rate is irregular
  • Ventricular bigeminy
  • Ventricular trigeminy
  • Couplet
102
Q

When do ventricular contractions occur?

A

oStimulants (caffeine, alcohol, nicotine) digoxin, aminophylline, fever, hypoxia, exercise, emotional stress, MI, HF, CAD, electrolyte imbalance (K, Mg)

103
Q

What are signs and symptoms, complications, and treatments of ventricular contractions?

A
S/S
Can be benign
oReduced cardiac output, CP, HF, pulse deficit
•Complication
oVentricular Tachycardia – 3 or more PVCs together
•Treatment
oTreat cause
oB Blockers
104
Q

What is ventricular Tachycardia? When Does it Occur?

A

Ventricular rate 150-250 bpm- regular or irregular
•Sustained VT - >30 seconds
•Nonsustained VT - <30 seconds
•Can be lethal
•Can occur with
oMI, CAD, significant electrolyte imbalance (K, Mg)
oPossible in patients without evidence of heart disease

105
Q

What are signs and symptoms of Ventricular Tachycardia?

A

oSevere decreased cardiac output

§Hypotension, pulmonary edema, decreased cerebral blood flow, cardio-pulmonary arrest

106
Q

What are complications of Vent Tachy?

A

•Complications

oVentricular fibrillation/ Death

107
Q

What are treatment options for Vent Tachy?

A

B Blockers, antidysrhythmics, cardioversion/defib

108
Q

What is Ventricular Fibrilation? S/s? Complications? Treatment?

A
•The ventricle is quivering, no contraction, no cardiac output
•Heart rate is not measureable-no pulse
•Can occur with
oMI, HF, sustained Vtach, hyperkalemia
•S/S
oUnresponsive, pulseless, apneic
•Complications
oDeath
•Treatment
Immediate CPR and ACLS, defibrillation
109
Q

What is Asystole? S/S? Complications? Treatment?

A

Asystole
•Represents total absence of ventricular electrical activity
•No ventricular contraction occurs because depolarization does not occur.
•Can occur with
oAdvanced cardiac disease such as end stage HF
•S/S
oUnresponsive, pulseless, and apneic state
•Complication
oDeath
•Treatment
CPR and ACLS

110
Q

What causes most sudden cardiac deaths?

A

Ventricular dysrhythmias (tachycardia and Fib, though fib is most common)

111
Q

Risk factors for Heart Failure

A
oCoronary artery disease (CAD) 
oHypertension
oMyocardial infarction 
oAdvancing age
oDiabetes
oCigarette smoking
oObesity
oHigh serum cholesterol
112
Q

What is a normal ejections fracture?

A

55-60%

113
Q

When would you see a mixed systolic and diastolic heart failure?

A

Dialated cardiomyopathy, high pulmonary pressures, biventricular failure

114
Q

What happens with right side heart failure?

A
oHepatomegaly
oSplenomegaly
oCongestion of the GI tract
oJugular vein distention (JVD) 
oPeripheral edema
115
Q

Manifestations of Chronic Heart Failure

A
  • Fatigue
  • Dyspnea
  • Paroyxsmal nocturnal dyspnea
  • Tachycardia
  • Edema
  • Nocturia
  • Skin changes
  • Behavioral changes
  • Chest pain
  • Weight changes
116
Q

What are some diagnostic studies used to determine Chronic Heart Failure?

A
•History, physical examination
•Chest x-ray
•Electrocardiogram (ECG)
•Stress testing 
•Laboratory data 
oCardiac enzymes, b-type natriuretic peptide [BNP], basic metabolic panel, liver function studies, complete blood count 
•Echocardiogram 
•Cardiac catheterization
•Endomyocardial biopsy (new unexplained HF)
•B type Natriuretic Peptide Assay (BNP)
oBNP is excreted from cardiac membranes
in response to ventricular volume expansion and pressure overload in HF
o>100pg/ml – predictor of HF
117
Q

Chronic Heart Failure Assessment Findings

A
Expected assessment findings
•Resp
oCrackle lung sounds, cough, pulse ox
•CV
oIrregular heart rhythm, rate, and sounds, murmur, edema, decreased perfusion
•GI
oEdema, enlarged liver and spleen, appetite
•GU
oDecreased urine output
•Skin
oEdema, temp, color
•MS
oDecreased activity tolerance, adl’s
•Mental Status
oOrientation
oLOC
oBehavioral change
•Psych/soc
oCoping, depression
118
Q

Nursing Interventions for Chronic Heart Failure

A
•High fowlers position
•Oxygen therapy
•Vital signs and ECG monitoring
oMonitor laboratory values (H/H, BNP, MG, K, BUN, Cr)
•Intake/output
•Daily weights
•Administer medications
•Patient teaching
•Cardiac resynchronization therapy (if uncontrolled Afib occurs)
119
Q

Drug Therapy for Chronic Heart Failure

A

•Diuretics-mobilize fluid, reduce pulmonary venous pressure, reduce preload-risk for electrolyte imbalance.
•Angiotensin-converting enzyme (ACE) inhibitors are the primary drug of choice in chronic HF patients with systolic dysfunction.
•Vasodilator-improving EF through improved ventricular contraction.
•Angiotensin II receptor blockers (ARB)- may be used in patients who are ACE inhibitor intolerant.
•β-Adrenergic blockers in combination with ACE inhibitors and diuretics have improved survival of patients with HF.
•Digitalis glycosides-risk for digoxin toxicity.
•Morphine-decrease anxiety, preload and afterload
•Antidysrhythmics-prevent and treat dysrhythmias
•Anticoagulants-prevent thromobembolism
oRecommended for all patients with EF<20% and /or Afib

120
Q

Patient Education for CHF

A

Diet Education and Weight Management
•Diet education and weight management are critical to the patient’s control of chronic HF.
oDietary restriction of sodium. (2000mg NA)
oIn moderate to severe HF fluid is restricted to < 2000ml daily
oDaily weight
§Contact primary care provider for a weight gain of 3 lb over 2 days, or 3 to 5 lb over a week.

121
Q

CKMB lab

A

myocardial tissue injury

122
Q

Troponin

A

released following an MI

123
Q

Myoglobin

A

Myocardial injury

124
Q

C-reactive protein

A

Inflammation can predict cardiac disease and events

125
Q

BNP > 100

A

Diagnostic for HF

126
Q

Cholesterol

A

Elevated = risk for atherosclerotic HD

127
Q

Triglycerides

A

Elevated is associated with CV disease and diabetes

128
Q

ECG

A

Can detect heart rhythms, presence of injury, or MI

129
Q

Echo

A

can detect congenital defect, wall motion, and EJF

130
Q

Cardiac Cath

A

Measures pressures within heart chambers and EJF.

131
Q

Stress Test

A

Assess extent of cardiovascular disease